Shire Targets Apotex Over Plan For Generic ADHD Drug
By Cara Salvatore ( November 25, 2013, 3:16 PM EST) -- Shire LLC accused generic-drug maker Apotex Inc. on Thursday of violating its intellectual property by seeking to sell a copy of Shire's attention deficit hyperactivity disorder drug Intuniv before the patents covering it expired....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.